Evidence map›Paper›PMID 19826133›Full record

Trial reportJournal of clinical oncology : official journal of the American Society of Clinical Oncology2009

Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening.

Veena Shankaran, Thanh Ha Luu, Narissa Nonzee, Elizabeth Richey, June M McKoy, Joshua Graff Zivin, Alfred Ashford, Rafael Lantigua, Harold Frucht, Marc Scoppettone and 2 more

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Multilevel interventions: measurement and measures.Journal of the National Cancer Institute. Monographs · 2012
    Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Veena ShankaranVeterans Affairs (VA) Chicago Healthcare System and VA Center for Management of Complex and Chronic Care, Chicago, IL, USA.
Thanh Ha Luu
Narissa Nonzee
Elizabeth Richey
June M McKoy
Joshua Graff Zivin
Alfred Ashford
Rafael Lantigua
Harold Frucht
Marc Scoppettone
Charles L Bennett
Sherri Sheinfeld Gorin
Columbia University · USRoyal College of Physicians · GBColumbia College · CAUniversity of California, San Diego · US

Funding

Adverse Drug Reactions in Geriatric Cancer PatientsK01CA134554 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MCKOY, JUNE M. · 2008 to 2012
$737k
NCI NIH HHS 1K01CA134554-01NCI NIH HHS K01 CA134554
6 · The paper itself

Abstract

purposeColorectal cancer (CRC) screening remains underutilized in the United States. Prior studies reporting the cost effectiveness of randomized interventions to improve CRC screening have not been replicated in the setting of small physician practices. We recently conducted a randomized trial evaluating an academic detailing intervention in 264 small practices in geographically diverse New York City communities. The objective of this secondary analysis is to assess the cost effectiveness of this intervention.

methodsA total of 264 physician offices were randomly assigned to usual care or to a series of visits from trained physician educators. CRC screening rates were measured at baseline and 12 months. The intervention costs were measured and the incremental cost-effectiveness ratio (ICER) was derived. Sensitivity analyses were based on varying cost and effectiveness estimates.

resultsAcademic detailing was associated with a 7% increase in CRC screening with colonoscopy. The total intervention cost was $147,865, and the ICER was $21,124 per percentage point increase in CRC screening rate. Sensitivity analyses that varied the costs of the intervention and the average medical practice size were associated with ICERs ranging from $13,631 to $36,109 per percentage point increase in CRC screening rates.

conclusionA comprehensive, multicomponent academic detailing intervention conducted in small practices in metropolitan New York was clinically effective in improving CRC screening rates, but was not cost effective.

Indexed as

Colorectal NeoplasmsCost-Benefit AnalysisEarly Detection of CancerHealth PersonnelHealth PromotionHumansMass ScreeningModels, EconomicPractice Patterns, Physicians'

Identifiers

PMID19826133
PMCPMC2773222
OpenAlexW2110184691

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.